It has been suggested that the transmission of skin-sensitizing antibodies from the maternal to the fetal circulation may be a factor in the development of allergic diseases. Certain other antibodies such as diphtheria antitoxin, typhoid agglutinin, tetanus antitoxin, hemolysins, and bacteriolysins, have been shown to pass through the human placenta from mother to fetus. Excellent reviews of this subject have been published by Ratner, Jackson, and Gruehl (1), Bell and Erickkson (2), Lippard and Wheeler (3), and Wiener and Silverman (4) and others. Placental transmission of antibodies responsible for anaphylactic shock has been demonstrated in the lower animals by Rosenau and Anderson (5), Otto (6), Wells (7), Schenck (8), Lewis (9), Ratner and his coworkers (10), and Cohen and Woodruff (11). Cohen, Cohen, and Hawver (12) reported the presence of skin-sensitlzing antibodies in the blood of a newborn rhesus monkey after injection of a sensitive human serum into the mother within 7 days prior to delivery.
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Placental transmission of skin-sensitizing antibodies in the human being has not been shown. Bell and Erickkson (2) were unable to demonstrate in the cord sera of 10 allergic mothers the skin-sensitizing antibodies that were shown to be present in the maternal sera in various dilutions. Caulfeild (13) also reported inability to demonstrate skin-sensitizing antibodies in the cord sera of 2 allergic mothers. Walzer (14) in a discussion of Bell's paper supported Bell's findings. Zohn (15) was unable to show such antibodies in the cord blood of 11 women actively sensitized and skin-reactive to Ascaris lumbricoides, although the maternal blood of 9 of the women was positive by passive transfer tests.
Wiener and Silverman (4), on the basis of titratiorr of the hemagglutinin content of maternal and cord blood, reported that "the index of permeability of the human placenta to antibodies or the coefficient of distribution of antibodies between maternal and cord blood" falls between 8 and 16. They suggested that the failure to detect placental transmission of skin-sensitizing antibody was due to the small amounts present in the maternal blood and lack of quantitative studies thereof.
Although all the direct evidence has shown there is no transmission of skin-sensitizing antibodies through the human placenta, the apparently contradictory evidence of transmission of other human antibodies and of certain anaphylactic antibodies in experimental animals has caused many to doubt that the point was completely proved. Therefore, it seems worth 611 while to report quantitative studies confirming the findings of Bell and Erickkson.
In the present investigation, observations have also been made on the transmission from the mother to the fetus of the "blocking" or "immune" antibody which is present in the serum of hay fever patients after treatment with injections of pollen extract. The presence of such an antibody, distinct from the skin-sensitizing antibody, was suggested by Cooke, Barnard, Hebald, and Stull (16) . Further evidence of its existence was given by Loveless (17) , who demonstrated that the skin-sensitizing antibody was destroyed by heat, while the new antibody produced in response to treatment was not destroyed.
Titration of Skin-Sensitizing Antibody
Twelve sera from allergic pregnant women, drawn during the latter half of pregnancy, were shown to contain skin-sensitizing antibodies to various antigens. At the time of delivery, blood was obtained from the umbilical cord using sterile precautions. In six cases, samples of colostrum were also obtained. The sera were separated from the clotted bloods, passed through Seitz filters, proved sterile by culture, and Kline tests were performed. Passive transfer studies were carried out in the skin of test subjects non-reactive to those aliergen extracts tested. The corresponding maternal serum, cord serum, and colostrum were studied in the same test subject. Skin sites were prepared with 0.1 cc. of concentrated serum and its dilutions 1-10, 1-100, 1-1000, and 1-10,000 in saline, and tested 48 hours later with 0.025 cc. of allergen extract containing 1000 protein nitrogen units t per cc.
Each of the maternal sera reacted in passive transfer sites with one or more allergen extracts, including ragweed, timothy, plantain, sorrel, ash, and birch pollen, cottonseed, kapok, dust, wheat, dog and horse dander (Table  I) . Ten of the 12 sera were positive in a dilution of 1-100 and 3 sera were still positive in a dilution of 1-1000. The 12 corresponding cord sera were tested with the same antigens but none gave positive passive transfer reactions. Two of the 6 colostra tested gave slight reactions in the concentrated form but none reacted in the 1-10 dilution. The 2 samples of colostrum which reacted were from mothers whose own sera in dilutions of 1-100 to 1-1000 reacted to the same antigen.
Seven of the infants at ages of 3 to 6 months were tested directly with extracts containing 100 or 1000 units of the allergen to which the mother's 
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serum reacted in passive transfer, and blood was drawn for passive transfer studies. In all cases, both the direct tests and the passive transfer reactions were negative (Table I) .
Placental Extract.--It has been suggested that the skin-sensitizing antibodies are intercepted in the cells of the placenta separating maternal and fetal circulation because of the normal affinity of these antibodies for cells. On the basis of this theory, an attempt was made to recover skin-sensitizing antibodies from the placenta. A whole placenta (case Aro.) was perfused with saline until the perfusate was free of blood. The placenta was then ground in a meat grinder and subsequently in a ball mill with a small amount of extracting fluid (containing 0.5 per cent NaC1 and 0.35 per cent NaHCO3) for 2 hours at 7°C. The extract was filtered through a Seitz filter and tested in passive transfer sites as were the sera. A second placenta (case Jpr.) was treated in the same manner, except that it was extracted with distilled water instead of the saline extracting fluid. A portion of this material was then frozen with dry ice and allowed to thaw in an attempt to rupture cell membranes. After being filtered through a Seitz filter and proved sterile, the extract was tested by passive transfer as were the sera. Neither the saline extract, nor the water extract, nor the water extract of the frozen placenta showed evidence of the skin-sensitizing antibodies which were demonstrated in the maternal sera.
Titration of Blocking Antibodies
Seven of the cord sera were from ragweed hay fever patients who had received injections of pollen extract before the babies were born. In these sera, the presence of blocking antibody was tested by mixing the sera with low ragweed pollen extract and injecting the mixtures into the skin sites which had been passively sensitized to ragweed. Table II represents a typical experiment. Six rows each of six identical sites were prepared by the intracutaneous injection into each site of 0.1 cc. of a 1-10 dilution of serum from an untreated case of ragweed hay fever (serum Rr.). The serum chosen reacted strongly in passive transfer sites with the fraction (fraction 1) of low ragweed pollen extract prepared from whole extract by precipitation at pH 4 with 50 per cent ammonium sulfate but reacted only slightly with the fraction (fraction 2) prepared by subsequent precipitation with completely saturated ammonium sulfate at the same pH (18) . Other experiments have indicated that the blocking antibody of post treatment hay fever sera often inactivates fraction 1 but not fraction 2, so that the blocking effect of serum on whole low ragweed pollen extract is more apparent when tested on sites prepared with a serum reacting mainly to fraction
The mixtures for testing were prepared by mixing 0.1 cc. of each cord serum with 0.9 cc. of low ragweed pollen extract containing 10 units per cc. Three control mixtures were made, 2 with cord sera from mothers who were not sensitive to ragweed and had not received injections of pollen extract and one with normal adult serum. The mixtures were kept overnight at 7°C. and each was then diluted 1-3, 1-9, 1-27, 1-81, and 1-243. The dilutions of each mixture were used to test one row of skin sites.
The serum-ragweed mixtures made with the 3 control sera gave reactions in higher dilution than the mixtures containing the cord sera of ragweed-treated mothers. The ragweed in the latter mixtures had been (Table II) .
In such experiments, the 7 cord sera from cases treated with ragweed pollen extract were compared with 2 control cord sera from cases which had not received pollen injections, with serum of a normal untreated adult, and with mixtures made with saline instead of serum. The various control mixtures gave identical results in all comparisons, showing that cord serum from untreated cases did not contain any non-specific inhibiting agent. All 7 cord sera from treated mothers when compared with the control sera showed evidence of inactivation of ragweed pollen extract. Since different test subjects show slight variation in reactivity of skin sites, the reactions of the serum tested must be compared with the control serum tested simultaneously in the same test subject.
These 7 cord sera were also compared with the corresponding maternal sera in similar experiments. Since the maternal sera contained skin-sensitizing antibodies, they were heated for 4 hours at 56°C. in order to destroy this activity. The cord and control sera were also heated so as to maintain comparable conditions. It is apparent that this heating did not materially affect the blocking activity of the cord sera. All heated maternal sera failed to sensitize normal skin. Table III shows typical results. The cord sera used in this experiment showed more blocking activity than those used in Table II , so that the ragweed was completely inactivated in the strength used. In every case the corresponding cord and maternal sera showed roughly comparable blocking activity. Exact quantitative comparisons could not be made, as in most of the cases several weeks elapsed between the drawing of the maternal and cord bloods. Some of the mothers received additional injections during this interval, others allowed the treatment to lapse. Three of the infants' sera taken at 3 to 6 months of age were studied for the presence of blocking antibody. In Table IV , 2 of these infant sera are compared with the corresponding cord sera and the same control cord serum used in the previous experiment. This experiment shows that the blocking antibody had practically disappeared within 3 to 6 months, although in one case (Adz.) the corresponding cord serum showed a large amount of antibody. The third infant serum, not represented in the table, showed no evidence of any immune antibody, although the corresponding cord serum did.
Titration of Other Antibodies
For comparison with the skin-sensitizing and blocking antibodies, the placental transmission of certain other antibodies present in the same maternal sera was studied.
Hemagglutinins.--The hemagglutinin content of maternal, cord, and infant sera was determined in the manner similar to that suggested by Wiener (4). 0.2 cc. of progressively doubled dilutions of the sera were mixed with equal volumes of a 2{ per cent suspension of known type A and also with known type B human blood cells. The mixtures were incubated at 37°C. for 2 hours and read by macroscopic and microscopic examination. Interpretations were recorded "positive" to the last dilution showing any degree of agglutination by microscopic examination. Table V shows the results of titration of the hemagglutinin content of 11 maternal, 10 cord, and 6 infant sera. Four of the 10 cord sera showed hemagglutinins, although it has been shown that none of the cord sera possessed any skin-sensitizing antibodies. The ratio of cord serum hemagglutinins to maternal serum hemagglutinins ranged between 2 and 32 in the four instances where cord hemagglutinins were present and studied in dilutions.
Shick Test.--Schick tests were performed on the mothers during pregnancy and upon 6 of the infants at ages 3 to 6 months, using the toxin obtained from the New York City Board of Health. Each infant reacted with the same result (negative or positive) as the corresponding mother (Table VI) .
Typhoid Agglutinins.--In one case, the mother had received three injections of triple typhoid vaccine 3 months prior to delivery, The maternal and cord sera each agglutinated a suspension of formalized typhoid organisms at a dilution of 1-100. The infant serum, however, taken at 3 months, failed to show agglutinins. This finding is in accordance with previous investigations.
DISCUSSION
The findings support those of Bell and Erickkson, in that the naturally occurring skin-sensitizing antibodies of human allergy are not transmitted through the human placenta. It was impossible by quantitative dilution tests to establish an index of permeability of the placenta to these antibodies such as was suggested by Wiener and Silverman (4) . In this study, even when skin-sensitizing antibodies were demonstrated in the maternal sera when diluted I00 or 1000 times, the same antibodies could not be demonstrated in the corresponding undiluted cord sera.
Four of the 10 cord sera studied contained hemagglutinins and 4 infants and their mothers showed negative reactions by the Schick test (indicating immunity or placental permeability for diphtheria antibody) yet the cord sera of these same cases did not show skin-sensitizing antibodies.
The demonstration that cord serum of hay fever patients, who had received injections of ragweed pollen extract, inactivates the pollen extract but does not sensitize normal skin is further evidence of coexistence of two distinct antibodies for ragweed pollen in the blood of treated cases.
It might be supposed that the presence of blocking antibody in the cord serum was due to active immunization of the fetus by pollen antigen passing through the placenta and not to transmission of blocking antibody. In all of the eases, the mothers had received injections of ragweed pollen extract during pregnancy. There is no direct evidence concerning the passage of this antigen through the placenta or of the ability of the fetus to form blocking antibody, but Cooke, Loveless, and Stull (20) have shown that such an antibody can be found in the sera of non-sensitive adults who received ragweed pollen injections. However, quantitative considerations make it seem unlikely that the blocking antibody in the cord serum was produced by the non-sensitive fetus. The normal adults described by these authors showed evidence of blocking antibody only after total doses of 200,000 to 1,000,000 units of ragweed pollen extract, doses much greater than those required by hay fever patients sensitive to ragweed; such as, the ragweed sensitive mother (case Aro.) who had received a total of only 4140 units of ragweed extract, but whose own serum and the cord serum of her non-sensitive infant showed marked blocking antibody. Furthermore, the degree of blocking activity of the maternal and cord sera in each case was as nearly comparable as could be expected considering the time in-terval and further treatment that intervened between the taking of the 2 sera. This was better shown in some of the other cases where the blocking activity of the maternal and cord sera was less than that of the sera shown in Table III and in which the ragweed extract was only partially inactivated in the range of dilutions used.
The disappearance of the blocking antibody from the infants' sera within 3 to 6 months after birth corresponds with the known facts regarding certain antibodies, such as typhoid agglutinin, known to be passively transmitted to the fetus through the placenta. The disappearance of blocking antibody from the serum of actively immunized hay fever patients is slower. For example, the maternal serum (case Aro.) was taken 4 months after the last injection of pollen extract, yet it showed active blocking antibody. For all of these reasons, although the possibility of passage of the antigen through the placenta cannot be definitely excluded, it seems most probable that the fetus acquires the blocking antibody passively and not by active immunization.
The skin-sensitizing antibody which occurs spontaneously in the serum of allergic human beings differs from most induced antibodies not only in being thermolabile but also in its failure to pass through the placenta. The blocking antibody, which is developed in response to injections of pollen extract, resembles the antibody produced by injections of other antigens in thermostability and in readily passing through the placenta. The separation of the two antibodies without heating the serum definitely establishes that the blocking antibody is not formed from the skin-sensitizing antibody by heat.
The fact that 2 of the 6 colostra showed a small amount of skin-sensitizing antibody suggested that these antibodies may pass through some cell membranes. This conflicts with the hypothesis that failure of these antibodies to permeate the placenta is due to affinity for cells preventing it from passing through membranes. The concentration of antibody, however, was only one-hundredth to one-thousandth that of the corresponding maternal sera, and in view of the small volume of colostrum obtainable from these women, the actual amount of antibody so secreted must have been small. SUMMARY 1. Quantitative studies of the skin-sensitizing antibodies, blocking antibodies, and hemagglutinins in sera of allergic human beings have been made.
2. A comparison of 12 maternal and the 12 corresponding cord sera by the method of passive transfer showed the human placenta to be impermeable to skin-sensitizing antibodies. 3. Direct skin tests and passive transfer studies of 6 infants at the ages of 3 to 6 months showed negative reactions to the antigens to which their mothers were sensitive.
4. The blocking antibody present in the sera of hay fever patients after treatment with pollen extract injections was also demonstrated in the cord sera. The apparent placental transmission of this antibody gave further evidence that it was distinct from the skin-sensitizing antibody. Infant sera obtained at the ages of 3 to 6 months showed no evidence of this immune antibody.
5. The cord sera from 4 of these cases were shown to contain the same isoagglutinins as the maternal sera, showing that the placentas were permeable to these antibodies. The mothers and their offspring reacted alike to Schick testing.
6. Typhoid agglutinins were demonstrated in maternal and cord sera of an adult who previously received injections of triple typhoid vaccine, whereas the serum of the corresponding infant at the age of 3 months failed to show agglutinins.
